Additional Imaging Recs in Oncologic PET/CT Reports Often Unnecessary

Article

About half of additional imaging requests in oncologic PET/CT reports are unnecessary.

About half of additional imaging requests in oncologic PET/CT reports are unnecessary, said researchers from Brigham and Women’s Hospital in Boston. The results of their study were presented at the American Roentgen Ray Society Annual Meeting in Vancouver, Canada.

Radiologists and nuclear medicine physicians recommend additional imaging to confirm findings about 30 percent of the time. To assess the necessity of the additional scans, researchers looked at the records of 250 patients, 84 of whom had been recommended for additional imaging. Researchers found that 43 of the recommendations were not necessary and would not have affected patient outcome if they had not been done.

“We feel that some of the most important factors leading to unnecessary recommendations include reluctance of physicians to accept uncertainty regarding diagnosis, partly driven by medicolegal concerns, combined with a failure to fully consider the patients’ clinical circumstances and the likely cost-effectiveness of additional imaging tests,” said Atul Shinagure, MD, one of the study’s authors.

Referring physicians also did not follow through on the recommendations 70 percent of the time, the authors said. This may be because radiologists and nuclear medicine physicians might not have complete medical histories of patients referred for PET/CT imaging.

“Ordering clinicians usually know the patient record and history,” said Shinagare. “[This] may put them in a better position to judge the necessity of some recommended additional imaging.”
 

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.